HIV

Heart diseases contributed 28.1% of the total deaths in India, in 2016 compared to 15.2% in 1990

Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of Dolutegravir and Rilpivirine tablets used in treatment of HIV infection. The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing. The Dolutegravir and Rilpivirine tablets, 50 mg/25 mg had estimated annual sales of USD 666 million in the US, the company said citing IQVIA MAT September 2022 data.

The government is providing free lifelong antiretroviral medicines for people living with HIV under its National AIDS Control Programme, Union Minister of State for Health Bharti Pravin Pawar said

Three doses of HEPLISAV-B vaccine provide full protection to adults with HIV, who were never immunised against hepatitis B virus (HBV) either through vaccination or infection, according to a study. In the research presented at the annual IDWeek conference held in Washington, US from October 19 to 23, the researchers from University of Cincinnati and Cornell University tested the three-dose course of HEPLISAV-B among 68 adults living with HIV at 38 sites in the US, South Africa, and Thailand. None of the participants had either received a previous HBV vaccination or had evidence of a previous HBV infection - all were on antiretroviral therapy to combat infection by retroviruses such as HIV. Retroviruses are a group of viruses that contain two single-strand linear RNA molecules per virion, or a viral particle, and reverse transcriptase (RNA to DNA). Following the initial dose of HEPLISAV-B vaccine 0.5 milliliter (mL) as an intramuscular injection, the study participants received ...

Drug firm Lupin on Tuesday said it has received an approval from the US health regulator to market Darunavir Tablets, used to treat Human Immunodeficiency Virus (HIV) infection, in the American market. The Mumbai-based company said it is the exclusive first filer for 800 mg tablets and is eligible for 180-day exclusivity. Lupin will also potentially have shared 180-day exclusivity on the 600 mg tablets, it added. The company has received the approval from the US Food and Drug Administration (USFDA) for the medication in strengths of 600 mg and 800 mg, Lupin said. The drug firm's product is a generic equivalent of Janssen Products' Prezista Tablets. As per MAT June 2022 data, Darunavir tablets (600 mg and 800 mg) had estimated annual sales of USD 343 million in the US. Lupin shares were trading 2.17 per cent up at Rs 738.30 apiece on the BSE.

Medicines to treat diabetes, HIV, TB, contraceptives, hormonal medicines included in National List of Essential Medicines

Health Canada approved the request by Canadian Blood Services to end the policy that restricts homosexuals from donating blood for three months after engaging in gay sex

French researcher Luc Montagnier, who won a Nobel Prize in 2008 for discovering the HIV virus and more recently spread false claims about the coronavirus, has died at age 89, according to officials

Sustainability and development have been key goals for the group

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad

The product will be manufactured at the company's facility in Nagpur

Company plans to produce its jab at eight sites, including Serum Institute

The Haryana government will bring patients of the state suffering from cancer, HIV and serious kidney ailments under the ambit of its social security pension scheme.

The woes of MBBS students on Covid duty, many families continue to struggle for food and jobs, and lessons in living from the ocean-news relevant to India's fight against Covid-19

Approximately once every minute and 40 seconds, a child or young person under the age of 20 was infected with HIV last year, the UN Children's Fund (UNICEF) said on Wednesday

In a major study, researchers have identified the important factors which could be contributing to the chronic inflammation in people living with HIV.

Individuals with influenza-like illness symptoms, patients admitted with severe acute respiratory infection are to be tested.

Revised guidelines on home isolation of very mildly symptomatic, pre-symptomatic and asymptomatic patients supersede the order issued earlier

A combination of antiviral drugs commonly used to treat HIV showed no beneficial effects in patients hospitalised with COVID-19 in a large-scale randomised trial, scientists in the UK have found.

Indians have long seen deadlier diseases. We need to take all precautions and get on with our lives